• Ionizing Radiation Alters Neural Differentiation via PI3K-ST

  2026-06-01

  This study reveals that ionizing radiation (IR) provokes altered neuronal differentiation in C17.2 mouse neural stem-like cells by activating the PI3K-STAT3-mGluR1 and PI3K-p53 pathways. The findings offer mechanistic insights into IR-induced brain dysfunction and highlight signaling nodes critical for future research in neurogenesis and metabolic modulation.

• Candida albicans EVs Regulate Hyphal Development via NRG1 Up

  2026-06-01

  This study reveals that high concentrations of Candida albicans extracellular vesicles (EVs) inhibit self-hyphal formation by upregulating the NRG1 transcriptional repressor. These findings clarify a new layer of fungal self-regulation and suggest potential avenues for antifungal therapeutic strategies targeting EV-mediated pathways.

• Ginsenoside Rg1: Triterpene Saponin Workflows for Neuroprote

  2026-05-31

  Ginsenoside Rg1 empowers robust, reproducible neuroprotection research by restoring gut-immune-brain axis integrity after anesthetic challenge. This guide translates recent mechanistic discoveries into optimized protocols, troubleshooting insights, and actionable workflow enhancements for apoptosis and inflammation modelers.

• Photocatalytic NADH Oxidation: Mechanisms for Cancer Therapy

  2026-05-30

  This article reviews a pivotal study on intracellular photocatalytic NADH/NAD(P)H oxidation and its implications for targeted cancer therapy. By leveraging light-activated metal photocatalysts, the research demonstrates new strategies for disrupting cancer cell metabolism through redox imbalance, with significant prospects for refining noninvasive anticancer treatments.

• SAG (Smoothened Agonist): Precision Astrocyte Modulation for

  2026-05-29

  Explore how SAG, a potent Smoothened receptor agonist, enables targeted modulation of astrocyte reactivity and mitochondrial function for advanced neuroprotection. This article uniquely focuses on astroglial-neuronal crosstalk and practical assay design, setting it apart from previous overviews.

• Cediranib (AZD2171): Reliable Angiogenesis Inhibition in Can

  2026-05-29

  This article guides biomedical scientists through common in vitro assay challenges, demonstrating how Cediranib (AZD2171), SKU A1882, enables reproducible and quantitatively precise inhibition of VEGFR signaling. Scenario-driven insights highlight best practices for experimental design, protocol optimization, and product selection, grounded in evidence and real-world laboratory needs.

• MALAT1/miR-125b/STAT3 Axis Regulates Procalcitonin in Sepsis

  2026-05-28

  This study elucidates how the long noncoding RNA MALAT1 upregulates procalcitonin (PCT) expression in sepsis via the miR-125b/STAT3 pathway. The findings clarify PCT’s regulation in sepsis, providing a new mechanistic basis for biomarker development and therapeutic targeting.

• SU5416 (Semaxanib): Precision Angiogenesis Inhibitor for Tum

  2026-05-28

  SU5416 (Semaxanib) stands out as a selective VEGFR2 inhibitor, offering researchers a dual-action tool for dissecting angiogenic and immune pathways in tumor and vascular models. Its unique combination of anti-angiogenic potency and AHR agonism makes it ideal for advanced studies in cancer biology and pulmonary hypertension.

• BCKAs Aerobically Activate HIF1α in Vascular Cells: New Insi

  2026-05-27

  This study reveals that branched chain α-ketoacids (BCKAs) can activate HIF1α signaling in human vascular cells under normal oxygen conditions. These findings elucidate a novel metabolic pathway in vascular biology, with implications for understanding pulmonary hypertension and vascular remodeling.

• Practical Guide: Hematoxylin and Eosin Staining Kit (K1142)

  2026-05-27

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides a standardized, ready-to-use solution for visualizing cellular and tissue morphology in histopathological and cytological research. It is optimized for both paraffin-embedded and frozen tissue sections, but is not suitable for diagnostic or clinical use. This article outlines actionable workflow best practices and technical parameters to maximize reproducibility and staining quality.

• Rapamycin (Sirolimus): Advanced Pathway Modulation Beyond mT

  2026-05-26

  Explore the multidimensional research value of Rapamycin (Sirolimus) as a precise mTOR inhibitor. This article delves into advanced pathway cross-talk, unique mitochondrial disease applications, and emerging insights for tumor biology assay design.

• ATF4-Regulated Enhancer Programs Drive Liver Fibrosis via HS

  2026-05-26

  A recent study uncovers a non-canonical enhancer program regulated by ATF4 in hepatic stellate cells (HSCs) as a central driver of liver fibrosis. By identifying the decoupling of ATF4’s traditional unfolded protein response from a distinct pro-fibrotic transcriptional role, the research establishes new targets for ER stress research and therapeutic intervention.

• Amyloid β-Peptide (1-42): Mechanisms, Assays, and Research U

  2026-05-25

  Amyloid β-Peptide (1-42) (Aβ42 peptide) is central to Alzheimer's disease research, serving as a benchmark for studying neurotoxicity and amyloid pathology. Its mechanistic impact on neuronal viability and ion channel modulation is well-documented. APExBIO’s B6057 product enables reproducible in vitro and in vivo modeling of Aβ42-driven neurodegeneration.

• Amphotericin B in Fungal Biofilm Resistance: Mechanisms and

  2026-05-25

  Explore how Amphotericin B, a polyene antifungal antibiotic, overcomes fungal biofilm resistance and modulates immune signaling. This article delivers a research-driven perspective, integrating new insights from autophagy and PP2A studies to inform advanced fungal infection research.

• SU5416 (Semaxanib): Selective VEGFR2 Inhibitor for Angiogene

  2026-05-24

  SU5416 (Semaxanib) is a potent, highly selective VEGFR2 inhibitor widely used in angiogenesis and tumor biology research. Its efficacy in suppressing VEGF-induced endothelial proliferation and tumor vascularization is well-validated in both in vitro and in vivo models. As an AHR agonist, it also provides unique utility in immunomodulation studies.

473 records 11/32 page Previous Next First page 上5页 1112131415 下5页 Last page